BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 36051330)

  • 1. Tumor microenvironment involvement in colorectal cancer progression
    Novoa Díaz MB; Martín MJ; Gentili C
    World J Gastroenterol; 2022 Jul; 28(26):3027-3046. PubMed ID: 36051330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
    Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
    Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
    Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
    J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paired-like homeodomain transcription factor 2 strengthens chemoresistance in colorectal cancer by activating the Wnt/β-catenin axis.
    Shu Y; He C; Xiong Y; Lan J; Song R
    Neoplasma; 2021 May; 68(3):557-566. PubMed ID: 33780262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt/
    Yuan S; Tao F; Zhang X; Zhang Y; Sun X; Wu D
    Biomed Res Int; 2020; 2020():9390878. PubMed ID: 32258160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
    Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
    Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.
    Nie X; Liu H; Ye W; Wei X; Fan L; Ma H; Li L; Xue W; Qi W; Wang YD; Chen WD
    J Cell Mol Med; 2022 Feb; 26(4):1095-1112. PubMed ID: 34997691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockage of PD-L1 by FERMT3-mediated Wnt/β-catenin signalling regulates chemoresistance and immune evasion of colorectal cancer cells.
    Tang Y; Nan N; Gui C; Zhou X; Jiang W; Zhou X
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):988-997. PubMed ID: 35672907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking the Wnt/β‑catenin signaling pathway to treat colorectal cancer: Strategies to improve current therapies (Review).
    Chen Y; Chen M; Deng K
    Int J Oncol; 2023 Feb; 62(2):. PubMed ID: 36579676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway.
    Zheng K; Zhou X; Yu J; Li Q; Wang H; Li M; Shao Z; Zhang F; Luo Y; Shen Z; Chen F; Shi F; Cui C; Zhao D; Lin Z; Zheng W; Zou Z; Huang Z; Zhao L
    Cancer Lett; 2016 Jun; 376(1):178-87. PubMed ID: 27037061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GPER Agonist G1 Prevents Wnt-Induced
    Abancens M; Harvey BJ; McBryan J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer.
    Arqués O; Chicote I; Puig I; Tenbaum SP; Argilés G; Dienstmann R; Fernández N; Caratù G; Matito J; Silberschmidt D; Rodon J; Landolfi S; Prat A; Espín E; Charco R; Nuciforo P; Vivancos A; Shao W; Tabernero J; Palmer HG
    Clin Cancer Res; 2016 Feb; 22(3):644-56. PubMed ID: 26224873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced lncRNA STEAP3-AS1 activates Wnt/β-catenin signaling to promote colorectal cancer progression by preventing m
    Zhou L; Jiang J; Huang Z; Jin P; Peng L; Luo M; Zhang Z; Chen Y; Xie N; Gao W; Nice EC; Li JQ; Chen HN; Huang C
    Mol Cancer; 2022 Aug; 21(1):168. PubMed ID: 35986274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.